238 related articles for article (PubMed ID: 30673723)
21. Signatures of malaria vaccine efficacy in ageing murine immune memory.
Haussig JM; Burgold J; Hafalla JC; Matuschewski K; Kooij TW
Parasite Immunol; 2014 May; 36(5):199-206. PubMed ID: 24495208
[TBL] [Abstract][Full Text] [Related]
22. CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge.
Schmidt NW; Butler NS; Harty JT
Vaccine; 2009 Oct; 27(44):6103-6. PubMed ID: 19712771
[TBL] [Abstract][Full Text] [Related]
23. Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
Draper SJ; Biswas S; Spencer AJ; Remarque EJ; Capone S; Naddeo M; Dicks MD; Faber BW; de Cassan SC; Folgori A; Nicosia A; Gilbert SC; Hill AV
J Immunol; 2010 Dec; 185(12):7583-95. PubMed ID: 21098232
[TBL] [Abstract][Full Text] [Related]
24. Myeloid cell tropism enables MHC-E-restricted CD8
Hansen SG; Hancock MH; Malouli D; Marshall EE; Hughes CM; Randall KT; Morrow D; Ford JC; Gilbride RM; Selseth AN; Trethewy RE; Bishop LM; Oswald K; Shoemaker R; Berkemeier B; Bosche WJ; Hull M; Silipino L; Nekorchuk M; Busman-Sahay K; Estes JD; Axthelm MK; Smedley J; Shao D; Edlefsen PT; Lifson JD; Früh K; Nelson JA; Picker LJ
Sci Immunol; 2022 Jun; 7(72):eabn9301. PubMed ID: 35714200
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
26. Antigen export during liver infection of the malaria parasite augments protective immunity.
Montagna GN; Beigier-Bompadre M; Becker M; Kroczek RA; Kaufmann SH; Matuschewski K
mBio; 2014 Jul; 5(4):e01321-14. PubMed ID: 25073641
[TBL] [Abstract][Full Text] [Related]
27. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
28. Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.
van der Velden M; Rijpma SR; Verweij V; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Franke-Fayard BM; Russel FG; Janse CJ; Sauerwein RW; Koenderink JB
Am J Trop Med Hyg; 2016 Aug; 95(2):378-82. PubMed ID: 27296385
[TBL] [Abstract][Full Text] [Related]
29. A Natural Peptide Antigen within the Plasmodium Ribosomal Protein RPL6 Confers Liver T
Valencia-Hernandez AM; Ng WY; Ghazanfari N; Ghilas S; de Menezes MN; Holz LE; Huang C; English K; Naung M; Tan PS; Tullett KM; Steiner TM; Enders MH; Beattie L; Chua YC; Jones CM; Cozijnsen A; Mollard V; Cai Y; Bowen DG; Purcell AW; La Gruta NL; Villadangos JA; de Koning-Ward T; Barry AE; Barchet W; Cockburn IA; McFadden GI; Gras S; Lahoud MH; Bertolino P; Schittenhelm RB; Caminschi I; Heath WR; Fernandez-Ruiz D
Cell Host Microbe; 2020 Jun; 27(6):950-962.e7. PubMed ID: 32396839
[TBL] [Abstract][Full Text] [Related]
30. Prime-and-Trap Malaria Vaccination To Generate Protective CD8
Olsen TM; Stone BC; Chuenchob V; Murphy SC
J Immunol; 2018 Oct; 201(7):1984-1993. PubMed ID: 30127085
[TBL] [Abstract][Full Text] [Related]
31. Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes.
Sedegah M; Hollingdale MR; Farooq F; Ganeshan H; Belmonte M; Kim Y; Peters B; Sette A; Huang J; McGrath S; Abot E; Limbach K; Shi M; Soisson L; Diggs C; Chuang I; Tamminga C; Epstein JE; Villasante E; Richie TL
PLoS One; 2014; 9(9):e106241. PubMed ID: 25211344
[TBL] [Abstract][Full Text] [Related]
32. Novel Plasmodium antigens identified via genome-based antibody screen induce protection associated with polyfunctional T cell responses.
Schussek S; Trieu A; Apte SH; Sidney J; Sette A; Doolan DL
Sci Rep; 2017 Nov; 7(1):15053. PubMed ID: 29118376
[TBL] [Abstract][Full Text] [Related]
33. Cytomegaloviral determinants of CD8
Malouli D; Hansen SG; Hancock MH; Hughes CM; Ford JC; Gilbride RM; Ventura AB; Morrow D; Randall KT; Taher H; Uebelhoer LS; McArdle MR; Papen CR; Espinosa Trethewy R; Oswald K; Shoemaker R; Berkemeier B; Bosche WJ; Hull M; Greene JM; Axthelm MK; Shao J; Edlefsen PT; Grey F; Nelson JA; Lifson JD; Streblow D; Sacha JB; Früh K; Picker LJ
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33766849
[TBL] [Abstract][Full Text] [Related]
34. Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.
Sridhar S; Reyes-Sandoval A; Draper SJ; Moore AC; Gilbert SC; Gao GP; Wilson JM; Hill AV
J Virol; 2008 Apr; 82(8):3822-33. PubMed ID: 18256155
[TBL] [Abstract][Full Text] [Related]
35. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.
Billman ZP; Kas A; Stone BC; Murphy SC
Malar J; 2016 Apr; 15():238. PubMed ID: 27113469
[TBL] [Abstract][Full Text] [Related]
36. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response.
Overstreet MG; Cockburn IA; Chen YC; Zavala F
Immunol Rev; 2008 Oct; 225():272-83. PubMed ID: 18837788
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
[TBL] [Abstract][Full Text] [Related]
38. Designer Parasites: Genetically Engineered
Goswami D; Minkah NK; Kappe SHI
J Immunol; 2019 Jan; 202(1):20-28. PubMed ID: 30587570
[TBL] [Abstract][Full Text] [Related]
39. Experimental human challenge infections can accelerate clinical malaria vaccine development.
Sauerwein RW; Roestenberg M; Moorthy VS
Nat Rev Immunol; 2011 Jan; 11(1):57-64. PubMed ID: 21179119
[TBL] [Abstract][Full Text] [Related]
40. Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.
Longley RJ; Bauza K; Ewer KJ; Hill AV; Spencer AJ
PLoS One; 2015; 10(3):e0119880. PubMed ID: 25822951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
